Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond.
This review article by Dr. Madeleine Cunningham describes the process by which autoantibodies signal human neuronal cells and activate calcium calmodulin-dependent protein kinase II (CaMKII) in patients suffering from an infection mediated autoimmune disease process with psychiatric symptoms.
Schedule Your Personal Phone Consultation
Learn more about how the Cunningham Panel™ of tests can assist you in diagnosing these treatable autoimmune neurologic disorders. Schedule your personal phone consultation with a Moleculera Labs clinical staff member by completing the form below or call Amy Cross, RN, at 405-239-5254.